logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/09/2025
China and the United States have restarted trade negotiations at the working level.
Latest
3 m ago
Hangzhou City Accelerates the Development of Artificial Intelligence Terminal Industry Three-Year Action Plan Open for Public Comments.
4 m ago
According to a statement, ASML Holding NV (ASML) will invest 1.3 billion euros in Mistral AI's Series C financing, resulting in ASML holding approximately 11% of Mistral AI's shares after full dilution. ASML and Mistral AI also announced the establishment of a strategic partnership, with both parties exploring the use of artificial intelligence models in ASML's full range of products, as well as in research and development and operational processes. As part of the investment, ASML will have a seat on Mistral's strategic committee. ASML's Chief Financial Officer, Roger Dassen, will assume this role while continuing to fulfill his current responsibilities.
4 m ago
ASM will invest 1.3 billion euros in Mistral AI to become its largest shareholder.
5 m ago
Net inflow of funds from the South exceeds 7 billion Hong Kong dollars.
5 m ago
Biopharmaceutical company Tourmaline Bio's overnight trading soared more than 16% on news that Novartis has agreed to acquire the company for $48 per share in cash.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.